Lasa Supergenerics Ltd. Brokerage/Research Reports, analyst Research Reports - table view - Trendlyne

Lasa Supergenerics Ltd.

Strong Performer, Getting Expensive

Check Buy or Sell

87.25 -1.70 (-1.91%)

242.16% Gain from 52W Low

62,734 Volume

NSEJan 22, 2021 03:31 PM

Broker 1Year buys

1 active buys

Market Cap

Above industry Median

Lasa Supergenerics Ltd. share price forecast

The 1 reports from 1 analysts offering long term price targets for Lasa Supergenerics Ltd. have an average target of 84.00. The consensus estimate represents a downside of -3.72% from the last price of 87.25.

Share

Reco - This broker has downgraded this stock from it's previous report.
(eg. - Buy->Hold)

Target - Broker has maintained previous recommendation but reduced target price.

Reco - This broker has upgraded this stock from it's previous report.
(eg. - Sell->Hold)

Target - Broker has maintained previous recommendation but increased target price.

LASA

Click on any table column to sort reports by date, stock name, broker, price, target, upside or recommendation.

Summary	Date	Stock	Broker	Price at Reco.	Target	Price at reco Change since reco(%)	Upside(%)	Type	Report	Discuss
	2020-08-25	Lasa Supergenerics L.. +	Khambatta Securities	63.80	84.00	63.80 (36.76%)	Target met	Buy		Broker Report Lasa Supergener Khambatta Securities Increasing prevalence of zoonotic diseases will drive demand for veterinary API products globally. Increasing awareness about preventive animal healthcare and judicious... Share Share on Share on Share on Share on Like Comment
	2018-06-04	Lasa Supergenerics L.. +	Joindre Capital Services Reco Target	51.90	55.00	51.90 (68.11%)		Hold		Broker Report STOCK REVIEW NOTE Joindre Capital Services Lasa Supergenerics is a vertically integrated player spanning the entire veterinary, animal and human healthcare value chainfrom discovery-to-delivery, with established credentials in research, manufacturing and global marketing.Lasa is a veterinary API manufacturing entity For FY18 the company has reported a PAT of Rs 12.32 crs as compared to Rs 2.35 crs last year on a Topline of Rs 249 crs from Rs 220 crs last year. Operating EBIDTA in FY18 totalled Rs 41 crs as compared to Rs 18 crs recorded last year.... Share Share on Share on Share on Share on Like Comment
	2017-12-14	Lasa Supergenerics L.. +	Joindre Capital Services	134.90	225.00	134.90 (-35.32%)		Buy		Broker Report LASA SUPERGENERICS LIMITED Joindre Capital Services Lasa Supergenerics Limited (Lasa) is a vertically integrated player spanning the entire veterinary, animal and human healthcare value chain from discovery-to-delivery, with established credentials in research, manufacturing and global marketing.Lasa is a veterinary API manufacturing entity, which was acquired in April 2012. for around Rs 6 crs. OSCL acquired Lasa as a part of forward integration for some of its chemicals. From a revenue base of less than 10 crs before acquisition, Lasa has reached revenue of Rs 200 crs now The manufacturing base of Lasa is located at Mahad, in the Konkan region of Maharashtra. It specialises in... Share Share on Share on Share on Share on Like Comment